Issue 10, 2020

A novel artificial intelligence protocol for finding potential inhibitors of acute myeloid leukemia

Abstract

There is currently no effective treatment for acute myeloid leukemia, and surgery is also ineffective as an important treatment for most tumors. Rapidly developing artificial intelligence technology can be applied to different aspects of drug development, and it plays a key role in drug discovery. Based on network pharmacology and virtual screening, candidates were selected from the molecular database. Nine artificial intelligence algorithm models were used to further verify the candidates’ potential. The 350 training results of the deep learning model showed higher credibility, and the R-square of the training set and test set of the optimal model reached 0.89 and 0.84, respectively. The random forest model has an R-square of 0.91 and a mean square error of only 0.003. The R-square of the Adaptive Boosting model and the Bagging model reached 0.92 and 0.88, respectively. Molecular dynamics simulation evaluated the stability of the ligand–protein complex and achieved good results. Artificial intelligence models had unearthed the promising candidates for STAT3 inhibitors, and the good performance of most models showed that they still had practical value on small data sets.

Graphical abstract: A novel artificial intelligence protocol for finding potential inhibitors of acute myeloid leukemia

Supplementary files

Article information

Article type
Paper
Submitted
08 Jan 2020
Accepted
10 Feb 2020
First published
10 Feb 2020

J. Mater. Chem. B, 2020,8, 2063-2081

A novel artificial intelligence protocol for finding potential inhibitors of acute myeloid leukemia

X. Chen, H. Chen, Z. Chen, J. Gong and C. Y. Chen, J. Mater. Chem. B, 2020, 8, 2063 DOI: 10.1039/D0TB00061B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements